Header Logo

Connection

MOTHAFFAR RIMAWI to Cetuximab

Back to Details
This is a "connection" page, showing publications MOTHAFFAR RIMAWI has written about Cetuximab.
MOTHAFFAR RIMAWI
Connection Strength
0.025
Cetuximab
  1. TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer. J Clin Oncol. 2012 Jul 20; 30(21):2615-23.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.